| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/08/1999 | WO1999014231A3 Bifidus stimulating peptides and its uses |
| 07/08/1999 | WO1998045711A3 Assay for ligands to tyrosine kinase receptors |
| 07/08/1999 | DE19758059A1 Verwendung von Mannose zur Bekämpfung der Proteinverlust-Enteropathie Use of mannose to combat protein-losing enteropathy |
| 07/08/1999 | CA2316401A1 Modified deacetoxycephalosporin c synthase (daocs) and x-ray structure |
| 07/08/1999 | CA2316341A1 4-[aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor |
| 07/08/1999 | CA2315723A1 Indole derivatives useful a.o. for the treatment of osteoporosis |
| 07/08/1999 | CA2315144A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines |
| 07/07/1999 | EP0927254A1 Antagonists of interleukin-15 |
| 07/07/1999 | EP0927248A1 Secreted proteins and polynucleotides encoding them |
| 07/07/1999 | EP0927191A2 Anti-inflammatory peptides and uses thereof |
| 07/07/1999 | EP0927183A1 Spirocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927170A1 Piperazino derivatives as neurokinin antagonists |
| 07/07/1999 | EP0927168A1 1,3-diheterocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927163A1 Preparation of 1-butyl-4-piperidinylmethylamine |
| 07/07/1999 | EP0927161A1 Substituted cyclic amine metalloprotease inhibitors |
| 07/07/1999 | EP0927156A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/07/1999 | EP0927033A1 Retinoyloxy(substituted)alkylene butyrates useful for the treatment of cancer and other proliferative diseases |
| 07/07/1999 | EP0927031A1 Pharmaceutical preparation containing nimesulide for oral administration |
| 07/07/1999 | EP0927030A1 Use of aryl n-substituted carboxamides to kill tumors |
| 07/07/1999 | EP0759029B1 Modified milk growth factor |
| 07/07/1999 | CN1222074A Administration regimen of H+, K+-ATPase inhibitors |
| 07/07/1999 | CN1221627A Medicine for treating digestive system disease and its prepn. method |
| 07/07/1999 | CN1221626A Oral liquid for treating toothache and its prodn. method |
| 07/07/1999 | CN1221623A Compsn. for protecting drinker' health, and its prodn. method |
| 07/07/1999 | CN1221615A Instant powder for strengthening stomach and relieving dyspepsia |
| 07/07/1999 | CN1043997C 2,6-diaminopurine derivatives, its use and medicinal compsns. containing same |
| 07/07/1999 | CN1043994C Thionaphthene diazepine compound, its prodn. method and application |
| 07/06/1999 | US5919943 Inhibition of spla2 |
| 07/06/1999 | US5919829 Gastrin and cck receptor ligands |
| 07/06/1999 | US5919822 Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients |
| 07/06/1999 | US5919810 1H-indole-3-glyoxylamide sPLA2 inhibitors |
| 07/06/1999 | US5919807 Benzothiazoles and benzoxazoles, drugs containing them, their use and methods of preparing them |
| 07/06/1999 | US5919789 Xanthines and their therapeutic use |
| 07/06/1999 | US5919763 IL-6/SIL-6R complex for promotion of liver functions |
| 07/06/1999 | US5919690 Dna sequence encoding a polypeptide derived from a strain of aspergillus having alpha-galactosidase activity which is not inhibited by galactose; host cells transformed for efficient biosynthesis of the galactosidase |
| 07/06/1999 | US5919660 Human requiem |
| 07/06/1999 | US5919455 Non-antigenic branched polymer conjugates |
| 07/06/1999 | US5919444 Method for decreasing severity of acute and chronic pancreatitis |
| 07/06/1999 | CA2182521C Method for reproducing in vitro the proteolytic activity of the ns3 protease of hepatitis c virus (hcv) |
| 07/06/1999 | CA2157397C Indole derivatives as 5-ht1-like agonists for use in migraine |
| 07/01/1999 | WO1999032645A1 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 07/01/1999 | WO1999032510A1 Kappa receptor opioid peptides |
| 07/01/1999 | WO1999032475A1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 07/01/1999 | WO1999032462A1 Triazine compounds for treatment of cns disorders |
| 07/01/1999 | WO1999032460A1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments |
| 07/01/1999 | WO1999032452A1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 07/01/1999 | WO1999032451A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals |
| 07/01/1999 | WO1999032437A1 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof |
| 07/01/1999 | WO1999032111A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS |
| 07/01/1999 | WO1999032110A1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS |
| 07/01/1999 | WO1999032107A1 Compositions comprising cannabinoids |
| 07/01/1999 | WO1999032099A2 Use of fucane for regulating the reconstruction of connective tissues |
| 07/01/1999 | WO1999032093A1 Oral pharmaceutical pulsed release dosage form |
| 07/01/1999 | WO1999032091A1 Oral pharmaceutical extended release dosage form |
| 07/01/1999 | WO1999018801A9 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 07/01/1999 | WO1999016741A3 Lipophilic diesters of chelating agents |
| 07/01/1999 | DE19830528A1 Multi-layer tablet comprising nutritious substances and microorganisms, and can be stored without cooling |
| 07/01/1999 | DE19752843A1 Pantoprazole and omeprazole film tablet and pellet used for treating conditions associated with elevated gastric acid secretion |
| 07/01/1999 | CA2315720A1 Inhibition of p38 kinase activity using substituted heterocyclic ureas |
| 07/01/1999 | CA2315620A1 Triazine compounds for treatment of cns disorders |
| 07/01/1999 | CA2314925A1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 07/01/1999 | CA2313316A1 Compositions comprising cannabinoids |
| 06/30/1999 | EP0925303A1 Phosphinic acid amides as matrix metalloprotease inhibitors |
| 06/30/1999 | EP0925299A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 06/30/1999 | EP0925298A1 Substituted 6,6-hetero-bicyclic derivatives |
| 06/30/1999 | EP0925294A1 Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels |
| 06/30/1999 | EP0925287A1 Heterocyclic metalloprotease inhibitors |
| 06/30/1999 | EP0925071A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
| 06/30/1999 | EP0924983A1 S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders |
| 06/30/1999 | CN1221449A Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 06/30/1999 | CN1221347A Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 06/30/1999 | CN1221344A Extractable compounds and method for making and using the same |
| 06/30/1999 | CN1220873A Method for manufacture troche for eliminating gastrointestinal vesicle and its application |
| 06/30/1999 | CN1043893C Pharmaceuticals |
| 06/30/1999 | CN1043887C Chemopreventive compound and preparation method and use thereof |
| 06/29/1999 | US5917014 Methods of treating inflammation and compositions therefor |
| 06/29/1999 | US5917007 Alkylated and crosslinked polyallylamine, polyvinylamine, polyethylenimine or diethylenetriamine-epichlorohydrin copolymer |
| 06/29/1999 | US5916922 For inhibiting human non-pancreatic secretory phospholipase a2 |
| 06/29/1999 | US5916906 Compositions comprising nicotinylalanine and an inhibitor of glycine conjugation or vitamin B6 |
| 06/29/1999 | US5916590 Soft gelatin pharmaceutical dosage form |
| 06/29/1999 | CA2131722C N,n'-disubstituted amide derivative |
| 06/29/1999 | CA2099856C Lactic acid bacterium |
| 06/29/1999 | CA1340617C Expression of hepatitis b s and pres2 protiens in methylotrophic yeasts |
| 06/24/1999 | WO1999031262A2 Needle-free injection of formulated nucleic acid molecules |
| 06/24/1999 | WO1999031116A1 Human dendriac and brainiac-3 |
| 06/24/1999 | WO1999031077A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 06/24/1999 | WO1999031075A1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 06/24/1999 | WO1999031074A2 ((cyclo)alkyl substituted)-.gamma.-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders |
| 06/24/1999 | WO1999031066A1 Pyridones as src family sh2 domain inhibitors |
| 06/24/1999 | WO1999031059A1 Potassium channel openers |
| 06/24/1999 | WO1999031057A1 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 06/24/1999 | WO1999030720A1 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 06/24/1999 | WO1999030710A1 USE OF PYRAZOLO [3,4-b] PYRIDINE AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 06/24/1999 | WO1999030562A1 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation |
| 06/24/1999 | DE19756388A1 New 2-aryl-4-amino-6,7-di:methoxy-quinazoline derivatives useful as guanylate cyclase activators for treating cardiovascular diseases, etc. |
| 06/24/1999 | DE19756036A1 New indole amide derivatives |
| 06/24/1999 | CA2506802A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 06/24/1999 | CA2315256A1 Needle-free injection of formulated nucleic acid molecules |
| 06/24/1999 | CA2314948A1 Potassium channel openers |
| 06/24/1999 | CA2314379A1 Human dendriac and brainiac-3 |